Reetoo Biotech was founded on August 1, 2017 with the registered office in Bao’an, Shenzhen. It boasts a 20,000㎡  modern R&D center and production base, currently employs over 500 people of whom more than 50% belong to the R&D team, and has established a nationwide sales and service network across 29 provinces in China.

    As the world’s only innovative supplier of full human-specimen, whole-process, full-automatic,   fully intelligent diagnostic products, Reetoo remains devoted to leading the IVD industry into the new era from automation to intelligence with AI 2.0 technologies being our cornerstone.

    We have successfully developed a new generation AI-based DeepCell engine, which has launched a full-specimen product line including 8 categories for testing on blood, leucorrhea, sperm, chromosomes, urine, feces, sputum and tissues, respectively, empowering clinical medicine with intelligent system solutions that have reshaped the medical laboratory landscape.

    We have established China's first AI-based medical laboratory innovation center, which is the founding member of the AI Branch of Guangdong Medical Laboratory Society.